AQST · Aquestive Therapeutics, Inc.
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 3, 4 and 5. Form 4 must be filed within two business days of the trade.
| Date | Insider | Role | Type | Security | Shares |
|---|---|---|---|---|---|
| 2026-07-16 | Barber Daniel |
President and CEO |
Sell↓
Filing footnotes — Common Stock (Direct)
The reported transaction involves sale transactions from $4.00 to $4.01 per share. The weighted average price per share was $4.00016. The Reporting Person undertakes to provide upon request by the SEC staff, the Issuer or a security holder of the Issuer, information regarding the number of shares sold at each separate price. |
Common Stock
|
20,369 |
| 2026-07-15 | Barber Daniel |
President and CEO |
Sell↓
Filing footnotes — Common Stock (Direct)
The reported transaction involves sale transactions from $4.00 to $4.04 per share. The weighted average price per share was $4.0344. The Reporting Person undertakes to provide upon request by the SEC staff, the Issuer or a security holder of the Issuer, information regarding the number of shares sold at each separate price. |
Common Stock
|
4,631 |
| 2026-06-23 | Krop Julie |
Chief Marketing Officer |
Convert↑
Filing footnotes — Common Stock (Direct)
This is a scheduled exercise from 10b5-1 trading plan. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was affected. |
Common Stock
|
25,000 |
| 2026-06-23 | Krop Julie |
Chief Marketing Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan previously adopted by the reporting person in this Form 4. |
Common Stock
|
25,000 |
| 2026-06-23 | Krop Julie |
Chief Marketing Officer |
Convert↓
Filing footnotes — Non-Qualified Stock Option (right to buy) (Direct)
This is a scheduled exercise from 10b5-1 trading plan. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was affected. This option was granted on June 22, 2022 and is fully vested. |
Non-Qualified Stock Option (right to buy)
|
25,000 |
| 2026-06-15 | Barber Daniel |
President and CEO |
Sell↓
Filing footnotes — Common Stock (Direct)
The reported transaction involves sale transactions from $4.14 to $4.235 per share. The weighted average price per share was $4.1604. The Reporting Person undertakes to provide upon request by the SEC staff, the Issuer or a security holder of the Issuer, information regarding the number of shares sold at each separate price. |
Common Stock
|
25,000 |
| 2026-06-10 | BROWN GREGORY B |
Director |
Award↑
Filing footnotes — Stock Option (Right to Purchase) (Direct)
The shares underlying the options vest as follows: 100% of the underlying shares vest June 10, 2027, subject to Dr. Brown's continuous service with the Issuer from the grant date through the applicable vesting date. |
Stock Option (Right to Purchase)
|
50,500 |
| 2026-06-10 | Jenkins Abigail L. |
Director |
Award↓
Filing footnotes — Non-Qualified Stock Option (right to buy) (Direct)
The shares underlying the options vest as follows: 100% of the underlying shares vest June 10, 2027, subject to Ms. Jenkins' continuous service with the Issuer from the grant date through the applicable vesting date. |
Non-Qualified Stock Option (right to buy)
|
50,500 |
| 2026-06-10 | Cochran John |
Director |
Award↑
Filing footnotes — Stock Option (Right to Purchase) (Direct)
The shares underlying the options vest as follows: 100% of the underlying shares vest June 10, 2027, subject to Mr. Cochran's continuous service with the Issuer from the grant date through the applicable vesting date. |
Stock Option (Right to Purchase)
|
50,500 |
| 2026-06-10 | MORRIS TIMOTHY E |
Director |
Award↑
Filing footnotes — Stock Option (right to purchase) (Direct)
The shares underlying the options vest as follows: 100% of the underlying shares vest June 10, 2027, subject to Mr. Morris' continuous service with the Issuer from the grant date through the applicable vesting date. |
Stock Option (right to purchase)
|
50,500 |
| 2026-06-10 | Taglietti Marco |
Director, Chief Executive Officer |
Award↑
Filing footnotes — Stock Option (Right to Purchase) (Direct)
The shares underlying the options vest as follows: 100% of the underlying shares vest June 10, 2027, subject to Dr. Taglietti's continuous service with the Issuer from the grant date through the applicable vesting date. |
Stock Option (Right to Purchase)
|
50,500 |
| 2026-06-10 | Krop Julie |
Chief Marketing Officer |
Award↑
Filing footnotes — Stock Option (Right to Purchase) (Direct)
The shares underlying the options vest as follows: 100% of the underlying shares vest June 10, 2027, subject to Dr. Krop's continuous service with the Issuer from the grant date through the applicable vesting date. |
Stock Option (Right to Purchase)
|
50,500 |
| 2026-06-08 | Korczynski Sherry |
Chief Commercial Officer |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. |
Common Stock
|
2,714 |
| 2026-05-18 | Zalewski Thomas A. |
Chief Legal Officer |
Award↑
Filing footnotes — Common Stock (Direct)
The Common Stock is represented by restricted stock which will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment. |
Common Stock
|
100,000 |
| 2026-05-18 | Zalewski Thomas A. |
Chief Legal Officer |
Award↑
Filing footnotes — Non-Qualified Stock Option (right to buy) (Direct)
The options will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment. |
Non-Qualified Stock Option (right to buy)
|
75,000 |
| 2026-05-15 | Barber Daniel |
President and CEO |
Sell↓
Filing footnotes — Common Stock (Direct)
The reported transaction involves sale transactions from $4.17 to $4.64 per share. The weighted average price per share was $4.2889. The Reporting Person undertakes to provide upon request by the SEC staff, the Issuer or a security holder of the Issuer, information regarding the number of shares sold at each separate price. |
Common Stock
|
8,257 |
| 2026-05-15 | Cioffi Melina |
SVP, Regulatory Affairs |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. |
Common Stock
|
1,667 |
| 2026-05-07 | BRAENDER LORI J |
Chief Legal Officer |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. |
Common Stock
|
135,690 |
| 2026-05-05 | Jung Cassie |
Chief Operating Officer |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Performance Stock Units ("PSUs") previously granted to the Reporting Person. |
Common Stock
|
72,734 |
| 2026-05-05 | Boyd Peter E. |
Chief People Officer |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Performance Stock Units ("PSUs") previously granted to the Reporting Person. |
Common Stock
|
56,778 |
| 2026-05-05 | Barber Daniel |
President and CEO |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Performance Stock Units ("PSUs") previously granted to the Reporting Person. |
Common Stock
|
335,922 |
| 2026-05-05 | BRAENDER LORI J |
Chief Legal Officer |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Performance Stock Units ("PSUs") previously granted to the Reporting Person. |
Common Stock
|
76,147 |
| 2026-05-05 | TOTH A ERNEST JR |
Chief Financial Officer |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Performance Stock Units ("PSUs") previously granted to the Reporting Person. |
Common Stock
|
92,652 |
| 2026-03-10 | Korczynski Sherry |
Chief Commercial Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. This transaction was executed in multiple trades at prices ranging from $4.17 to $4.32. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected. |
Common Stock
|
15,741 |
| 2026-03-10 | Cioffi Melina |
SVP, Regulatory Affairs |
Sell↓
Filing footnotes — Common Stock (Direct)
Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. This transaction was executed in multiple trades at prices ranging from $4.17 to $4.32. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected. |
Common Stock
|
25,311 |
| 2026-03-10 | Barber Daniel |
President and CEO |
Sell↓
Filing footnotes — Common Stock (Direct)
Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. This transaction was executed in multiple trades at prices ranging from $4.17 to $4.33. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected. |
Common Stock
|
180,677 |
| 2026-03-10 | BRAENDER LORI J |
Chief Legal Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. This transaction was executed in multiple trades at prices ranging from $4.17 to $4.32. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected. |
Common Stock
|
40,102 |
| 2026-03-10 | Boyd Peter E. |
Chief People Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. This transaction was executed in multiple trades at prices ranging from $4.17 to $4.33. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected. |
Common Stock
|
29,814 |
| 2026-03-10 | Jung Cassie |
Chief Operating Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. This transaction was executed in multiple trades at prices ranging from $4.17 to $4.32. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected. |
Common Stock
|
45,791 |
| 2026-03-10 | TOTH A ERNEST JR |
Chief Financial Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. This transaction was executed in multiple trades at prices ranging from $4.17 to $4.32. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected. |
Common Stock
|
58,254 |
| 2026-03-09 | TOTH A ERNEST JR |
Chief Financial Officer |
Award↑
Filing footnotes — Common Stock (Direct)
The Common Stock is represented by restricted stock which will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment. |
Common Stock
|
95,000 |
| 2026-03-09 | Barber Daniel |
President and CEO |
Award↑
Filing footnotes — Non-Qualified Stock Option (right to buy) (Direct)
The options will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment. |
Non-Qualified Stock Option (right to buy)
|
523,000 |
| 2026-03-09 | TOTH A ERNEST JR |
Chief Financial Officer |
Award↑
Filing footnotes — Non-Qualified Stock Option (right to buy) (Direct)
The options will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment. |
Non-Qualified Stock Option (right to buy)
|
70,000 |
| 2026-03-09 | Barber Daniel |
President and CEO |
Award↑
Filing footnotes — Common Stock (Direct)
The Common Stock is represented by restricted stock which will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment. |
Common Stock
|
262,000 |
| 2026-03-09 | Cioffi Melina |
SVP, Regulatory Affairs |
Award↑
Filing footnotes — Common Stock (Direct)
The Common Stock is represented by restricted stock which will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment. |
Common Stock
|
100,000 |
| 2026-03-09 | Korczynski Sherry |
Chief Commercial Officer |
Award↑
Filing footnotes — Non-Qualified Stock Option (right to buy) (Direct)
The options will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment. |
Non-Qualified Stock Option (right to buy)
|
42,500 |
| 2026-03-09 | Jung Cassie |
Chief Operating Officer |
Award↑
Filing footnotes — Common Stock (Direct)
The Common Stock is represented by restricted stock which will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment. |
Common Stock
|
80,000 |
| 2026-03-09 | BRAENDER LORI J |
Chief Legal Officer |
Award↑
Filing footnotes — Non-Qualified Stock Option (right to buy) (Direct)
The options will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment. |
Non-Qualified Stock Option (right to buy)
|
50,000 |
| 2026-03-09 | Boyd Peter E. |
Chief People Officer |
Award↑
Filing footnotes — Non-Qualified Stock Option (right to buy) (Direct)
The options will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment. |
Non-Qualified Stock Option (right to buy)
|
42,500 |
| 2026-03-09 | Boyd Peter E. |
Chief People Officer |
Award↑
Filing footnotes — Common Stock (Direct)
The Common Stock is represented by restricted stock which will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment. |
Common Stock
|
80,000 |
| 2026-03-09 | Korczynski Sherry |
Chief Commercial Officer |
Award↑
Filing footnotes — Common Stock (Direct)
The Common Stock is represented by restricted stock which will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment. |
Common Stock
|
75,000 |
| 2026-03-09 | BRAENDER LORI J |
Chief Legal Officer |
Award↑
Filing footnotes — Common Stock (Direct)
The Common Stock is represented by restricted stock which will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment. |
Common Stock
|
80,000 |
| 2026-03-09 | Davis Matthew W. |
Chief Development Officer |
Award↑
Filing footnotes — Non-Qualified Stock Option (right to buy) (Direct)
The option will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment. |
Non-Qualified Stock Option (right to buy)
|
50,000 |
| 2026-03-09 | Greenhawt Matthew J. |
Chief Medical Officer |
Award↑
Filing footnotes — Non-Qualified Stock Option (right to buy) (Direct)
The option will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment. |
Non-Qualified Stock Option (right to buy)
|
50,000 |
| 2026-03-09 | Davis Matthew W. |
Chief Development Officer |
Award↑
Filing footnotes — Common Stock (Direct)
The Common Stock is represented by restricted stock which will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment. |
Common Stock
|
50,000 |
| 2026-03-09 | Cioffi Melina |
SVP, Regulatory Affairs |
Award↑
Filing footnotes — Non-Qualified Stock Option (right to buy) (Direct)
The options will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment. |
Non-Qualified Stock Option (right to buy)
|
75,000 |
| 2026-03-09 | Jung Cassie |
Chief Operating Officer |
Award↑
Filing footnotes — Non-Qualified Stock Option (right to buy) (Direct)
The options will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment. |
Non-Qualified Stock Option (right to buy)
|
42,500 |
| 2026-03-09 | Greenhawt Matthew J. |
Chief Medical Officer |
Award↑
Filing footnotes — Common Stock (Direct)
The Common Stock is represented by restricted stock which will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment. |
Common Stock
|
75,000 |
| 2025-12-04 | Boyd Peter E. |
Chief People Officer |
Award↑
Filing footnotes — Common Stock (Direct)
The Common Stock is represented by restricted stock which will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment. |
Common Stock
|
20,000 |
| 2025-12-02 | Cioffi Melina |
SVP, Regulatory Affairs |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. |
Common Stock
|
2,083 |